Stocks Health care MAIA
NYSE · Health careMAIA Biotechnology, Inc. (MAIA)
It posted a net loss of $26.8M. At June 30, 2026 it held $0 in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
What MAIA Biotechnology, Inc. does
MAIA Biotechnology, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker MAIA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$22.4M | -$0.70 | n/a |
| 2024 | $0 | -$23.3M | -$1.05 | n/a |
| 2023 | $0 | -$19.8M | -$1.49 | n/a |
| 2022 | $0 | -$16.2M | -$1.75 | n/a |
| 2022 | n/a | -$12.5M | -$2.37 | n/a |
Latest SEC filings
What MAIA Biotechnology, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 25, 2026
- August 21, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026
- May 22, 2026
- May 19, 2026Additional proxy material DEFA14A
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 14, 2026
- May 14, 2026
- May 11, 2026Quarterly report 10-Q · period to March 31, 2026
Questions about MAIA
What does MAIA Biotechnology, Inc. do?
MAIA Biotechnology, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker MAIA.
Is MAIA Biotechnology, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $26.8M.
When did MAIA Biotechnology, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the shelf registration to sell securities from September 25, 2026.
Similar companies
Follow MAIA
Get an email when MAIA Biotechnology, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow MAIA: get an email when it filesWhere the numbers come from
Financial figures are the values MAIA Biotechnology, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.